Sampaio Francisco, Lamata Pablo, Bettencourt Nuno, Alt Sophie Charlotte, Ferreira Nuno, Kowallick Johannes Tammo, Pimenta Joana, Kutty Shelby, Fraga José, Steinmetz Michael, Bettencourt Paulo, Gama Vasco, Schuster Andreas
Cardiology Department, Centro Hospitalar de Gaia/Espinho, Rua Conceição Fernandes, 4430-502 Vila Nova de Gaia, Espinho, Portugal.
University of Porto Medical School, Porto, Portugal.
J Cardiovasc Magn Reson. 2015 Jul 18;17(1):61. doi: 10.1186/s12968-015-0157-6.
Liver cirrhosis has been shown to affect cardiac performance. However cardiac dysfunction may only be revealed under stress conditions. The value of non-invasive stress tests in diagnosing cirrhotic cardiomyopathy is unclear. We sought to investigate the response to pharmacological stimulation with dobutamine in patients with cirrhosis using cardiovascular magnetic resonance.
Thirty-six patients and eight controls were scanned using a 1.5 T scanner (Siemens Symphony TIM; Siemens, Erlangen, Germany). Conventional volumetric and feature tracking analysis using dedicated software (CMR42; Circle Cardiovascular Imaging Inc, Calgary, Canada and Diogenes MRI; Tomtec; Germany, respectively) were performed at rest and during low to intermediate dose dobutamine stress.
Whilst volumetry based parameters were similar between patients and controls at rest, patients had a smaller increase in cardiac output during stress (p = 0.015). Ejection fraction increase was impaired in patients during 10 μg/kg/min dobutamine as compared to controls (6.9 % vs. 16.5 %, p = 0.007), but not with 20 μg/kg/min (12.1 % vs. 17.6 %, p = 0.12). This was paralleled by an impaired improvement in circumferential strain with low dose (median increase of 14.4 % vs. 30.9 %, p = 0.03), but not with intermediate dose dobutamine (median increase of 29.4 % vs. 33.9 %, p = 0.54). There was an impaired longitudinal strain increase in patients as compared to controls during low (median increase of 6.6 % vs 28.6 %, p < 0.001) and intermediate dose dobutamine (median increase of 2.6%vs, 12.6 % p = 0.016). Radial strain response to dobutamine was similar in patients and controls (p > 0.05).
Cirrhotic cardiomyopathy is characterized by an impaired cardiac pharmacological response that can be detected with magnetic resonance myocardial stress testing. Deformation analysis parameters may be more sensitive in identifying abnormalities in inotropic response to stress than conventional methods.
肝硬化已被证实会影响心脏功能。然而,心脏功能障碍可能仅在应激状态下才会显现。非侵入性应激试验在诊断肝硬化性心肌病中的价值尚不清楚。我们旨在利用心血管磁共振成像研究肝硬化患者对多巴酚丁胺药物刺激的反应。
使用1.5T扫描仪(西门子Symphony TIM;德国埃尔朗根西门子公司)对36例患者和8名对照者进行扫描。使用专用软件(分别为加拿大卡尔加里Circle Cardiovascular Imaging公司的CMR42和德国Tomtec公司的Diogenes MRI)在静息状态和低至中等剂量多巴酚丁胺应激期间进行传统的容积分析和特征追踪分析。
虽然患者和对照者在静息状态下基于容积分析的参数相似,但患者在应激期间心输出量的增加较小(p = 0.015)。与对照者相比,患者在多巴酚丁胺剂量为10μg/kg/min时射血分数的增加受损(6.9%对16.5%,p = 0.007),但在20μg/kg/min时未受损(12.1%对17.6%,p = 0.12)。这与低剂量多巴酚丁胺时圆周应变改善受损相平行(中位数增加14.4%对30.9%,p = 0.03),但在中等剂量多巴酚丁胺时未受损(中位数增加29.4%对33.9%,p = 0.54)。与对照者相比,患者在低剂量(中位数增加6.6%对28.6%,p < 0.001)和中等剂量多巴酚丁胺(中位数增加2.6%对12.6%,p = 0.016)时纵向应变增加受损。患者和对照者对多巴酚丁胺的径向应变反应相似(p > 0.05)。
肝硬化性心肌病的特征是心脏药物反应受损,这可以通过磁共振心肌应激试验检测到。与传统方法相比,变形分析参数在识别应激性变力反应异常方面可能更敏感。